These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27037269)

  • 41. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.
    Chen Z; Maricic M; Bassford TL; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS
    Arch Intern Med; 2005 Mar; 165(5):552-8. PubMed ID: 15767532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study.
    Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Wolk A
    Int J Cancer; 2006 Oct; 119(7):1683-9. PubMed ID: 16646051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary levels of melatonin and risk of postmenopausal breast cancer: women's health initiative observational cohort.
    Sturgeon SR; Doherty A; Reeves KW; Bigelow C; Stanczyk FZ; Ockene JK; Liu S; Manson JE; Neuhouser ML
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):629-37. PubMed ID: 24510738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maximum and Time-Dependent Body Mass Index and Breast Cancer Incidence Among Postmenopausal Women in the Black Women's Health Study.
    Gathirua-Mwangi WG; Palmer JR; Champion V; Castro-Webb N; Stokes AC; Adams-Campbell L; Marley AR; Forman MR; Rosenberg L; Bertrand KA
    Am J Epidemiol; 2022 Mar; 191(4):646-654. PubMed ID: 35020804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anthropometric factors and physical activity and risk of thyroid cancer in postmenopausal women.
    Kabat GC; Kim MY; Thomson CA; Luo J; Wactawski-Wende J; Rohan TE
    Cancer Causes Control; 2012 Mar; 23(3):421-30. PubMed ID: 22212611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast Cancer Risk in Postmenopausal Women with Medical History of Thyroid Disorder in the Women's Health Initiative.
    Weng CH; Okawa ER; Roberts MB; Park SK; Umbricht CB; Manson JE; Eaton CB
    Thyroid; 2020 Apr; 30(4):519-530. PubMed ID: 31918623
    [No Abstract]   [Full Text] [Related]  

  • 47. Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status.
    Devore EE; Warner ET; Eliassen AH; Brown SB; Beck AH; Hankinson SE; Schernhammer ES
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):413-419. PubMed ID: 28151704
    [No Abstract]   [Full Text] [Related]  

  • 48. The association between DXA-derived body fat measures and breast cancer risk among postmenopausal women in the Women's Health Initiative.
    Arthur RS; Xue X; Kamensky V; Chlebowski RT; Simon M; Luo J; Shadyab AH; Neuhouser ML; Banack H; Ho GYF; Lane DS; Pan K; Reding KW; Wassertheil-Smoller S; Dannenberg AJ; Rohan TE
    Cancer Med; 2020 Feb; 9(4):1581-1599. PubMed ID: 31875358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone mass and the risk of breast cancer among postmenopausal women.
    Zhang Y; Kiel DP; Kreger BE; Cupples LA; Ellison RC; Dorgan JF; Schatzkin A; Levy D; Felson DT
    N Engl J Med; 1997 Feb; 336(9):611-7. PubMed ID: 9032046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women's Health Initiative observational study.
    Pressler M; Rosenberg CA; Derman BA; Greenland P; Khandekar J; Rodabough RJ; McTiernan A; Simon MS
    Breast Cancer Res Treat; 2013 Jun; 139(3):821-31. PubMed ID: 23760856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women.
    Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Sieri S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P
    J Natl Cancer Inst; 2008 Jun; 100(12):898-905. PubMed ID: 18544743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study.
    Harvie M; Howell A; Vierkant RA; Kumar N; Cerhan JR; Kelemen LE; Folsom AR; Sellers TA
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):656-61. PubMed ID: 15767346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer.
    Kabat GC; Kim M; Caan BJ; Chlebowski RT; Gunter MJ; Ho GY; Rodriguez BL; Shikany JM; Strickler HD; Vitolins MZ; Rohan TE
    Int J Cancer; 2009 Dec; 125(11):2704-10. PubMed ID: 19588485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort.
    Thiébaut AC; Kipnis V; Chang SC; Subar AF; Thompson FE; Rosenberg PS; Hollenbeck AR; Leitzmann M; Schatzkin A
    J Natl Cancer Inst; 2007 Mar; 99(6):451-62. PubMed ID: 17374835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in Overall Diet Quality in Relation to Survival in Postmenopausal Women with Breast Cancer: Results from the Women's Health Initiative.
    Sun Y; Bao W; Liu B; Caan BJ; Lane DS; Millen AE; Simon MS; Thomson CA; Tinker LF; Van Horn LV; Vitolins MZ; Snetselaar LG
    J Acad Nutr Diet; 2018 Oct; 118(10):1855-1863.e6. PubMed ID: 29859758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of urinary cadmium on mortality in the Japanese general population in cadmium non-polluted areas.
    Suwazono Y; Nogawa K; Morikawa Y; Nishijo M; Kobayashi E; Kido T; Nakagawa H; Nogawa K
    Int J Hyg Environ Health; 2014 Nov; 217(8):807-12. PubMed ID: 24924827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort.
    Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
    Int J Cancer; 2016 Nov; 139(10):2193-200. PubMed ID: 27451078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative.
    Drieling RL; LaCroix AZ; Beresford SA; Boudreau DM; Kooperberg C; Chlebowski RT; Gass M; Crandall CJ; Womack CR; Heckbert SR
    Menopause; 2016 Nov; 23(11):1168-1175. PubMed ID: 27433859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accelerometer-measured physical activity and postmenopausal breast cancer incidence in the Women's Health Accelerometry Collaboration.
    Hyde ET; LaCroix AZ; Evenson KR; Howard AG; Anuskiewicz B; Di C; Bellettiere J; LaMonte MJ; Manson JE; Buring JE; Shiroma EJ; Lee IM; Parada H
    Cancer; 2023 May; 129(10):1579-1590. PubMed ID: 36812131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of estrogen plus testosterone supplementation on breast cancer.
    Ness RB; Albano JD; McTiernan A; Cauley JA
    Arch Intern Med; 2009 Jan; 169(1):41-6. PubMed ID: 19139322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.